抗氨酸转化酶抑制剂诱导的血管
R Gentry Wilkerson1, Michael E Winters2
1Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA.
Immunology and allergy clinics of North America
|July 2, 2023
概括
ангиотензин转化酶抑制剂 (ACEi) 治疗可以导致血管,一种危险的胀. 这是因为ACE抑制剂阻断了布拉迪基宁的分解,导致液体积聚和潜在的呼吸道阻塞.
科学领域:
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
- 心脏病学 心脏病学
背景情况:
- ангиотензин转化酶抑制剂 (ACEi) 治疗广泛用于心血管疾病.
- 由ACEi诱导的血管是已知的,可能危及生命的不良影响.
- 该机制涉及由于ACE抑制代谢而积累的布拉迪基宁.
研究的目的:
- 审查ACEi诱导的血管的病理生理学和临床表现.
- 强调急诊医生在管理这种疾病中的关键作用.
- 要突出呼吸道评估和管理在受影响的患者的重要性.
主要方法:
- 关于ACEi诱导的血管的文献综述.
- 涉及ACE和布拉迪基宁的生物化学途径的分析.
- 临床案例讨论,重点关注紧急情况管理策略.
主要成果:
- ACE 抑制剂减少布拉迪基宁的分解,增加其水平.
- 升高的布拉迪基宁水平会导致血管透性增加和.
- 血管通常会影响脸部,嘴唇,舌头和呼吸道,造成危害的风险.
结论:
- 由ACEi诱导的血管内是由于布拉迪基宁的积累而产生的.
- 对于急诊医生来说,迅速的气道评估和管理是至关重要的.
- 了解该机制对于有效的患者护理和降低风险至关重要.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
698
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
698
Antihypertensive Drugs: Direct Renin Inhibitors
699
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
699
Antihypertensive Drugs: Angiotensin II Receptor Blockers
786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
202
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
202
Cardiac Catheterization I: Pre-Procedure Overview
72
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
72


